Wellpartner

Wellpartner

Comprehensive 340B program optimization with unmatched regulatory expertise and specialty pharmacy services. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD19—28m (Dealroom.co estimates Feb 2012.)
Portland Oregon (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Series A

$14.0m

Series B

$7.5m

Series C

$16.1m

Series D
N/A

$3.0m

Early VC

N/A

Acquisition
Total FundingAUD62.7m

Recent News about Wellpartner

Edit
More about Wellpartnerinfo icon
Edit

Wellpartner is a leading provider of services for the 340B Drug Pricing Program, which helps healthcare organizations optimize their 340B programs to better serve their patients. The company operates in the healthcare sector, specifically targeting covered entities such as hospitals and clinics that are eligible for the 340B program. Wellpartner's business model revolves around offering a suite of services including contract pharmacy administration, compliance monitoring, and specialty pharmacy services. These services are designed to maximize the value of the 340B program for their clients by ensuring regulatory compliance, optimizing claims, and providing access to a vast network of over 60,000 pharmacies. The company generates revenue through service fees charged to its clients for these specialized services. Wellpartner's unique selling points include its regulatory expertise, comprehensive program reviews, and seamless data integration capabilities. The company aims to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.

Keywords: 340B optimization, regulatory compliance, contract pharmacy, specialty pharmacy, healthcare, claims optimization, data integration, federal resources, patient services, pharmacy network.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.